ASMB
Assembly Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$36.60
+1.30%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.66
- Revenue estimate
- $9.1M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.20
- EPS estimate
- -$0.72
- Revenue actual
- $13.4M
- Revenue estimate
- $8.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +145.3%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $49
- PT range
- $45 – $52
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026